|
Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?
|
June 22, 2022
|
PC3I Authors Catherine Lai |
Clinical Advances in Hematology and Oncology
|
|
Air pollution and lung cancer survival in Pennsylvania
|
June 18, 2022
|
PC3I Authors Anil Vachani |
Lung Cancer
|
|
Impact of COVID-19 on gynecologic and obstetrical services at two large health systems
|
June 16, 2022
|
PC3I Authors Angela Liang |
Plos One
|
|
Invited Commentary: Crisis Preparedness in Surgery
|
June 16, 2022
|
PC3I Authors |
Journal of the American College of Surgeons
|
|
Development of a robust radiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first-line immunotherapy
|
June 15, 2022
|
PC3I Authors Charu Aggarwal |
Scientific Reports
|
|
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19
|
June 15, 2022
|
PC3I Authors Alix Seif; Allison Barz Leahy |
Clinical Cancer Research
|
|
Rural-urban disparities in place of death in hematologic malignancies in the United States, 2003 to 2019
|
June 15, 2022
|
PC3I Authors Ramy Sedhom |
Blood Advances
|
|
Effect of Text Messaging and Behavioral Interventions on COVID-19 Vaccination Uptake: A Randomized Clinical Trial
|
June 13, 2022
|
PC3I Authors Shivan Mehta |
JAMA Network Open
|
|
Trajectories of Pain Severity and Interference Among Adolescent and Young Adults With Cancer: A Microlongitudinal Study
|
June 10, 2022
|
PC3I Authors Lisa A. Schwartz |
The Clinical Journal of Pain
|
|
Reliability and Validity Testing of the Caregiver-Centered Communication Questionnaire
|
June 9, 2022
|
PC3I Authors George Demiris |
Journal of Nursing Measurement
|
|
Aumolertinib in EGFR-Mutant Lung Cancer: Will the Promise of Cost Disruption Ease Access?
|
June 9, 2022
|
PC3I Authors Charu Aggarwal |
Journal of Clinical Oncology
|
|
Association of the Affordable Care Act’s Medicaid Expansion With 1-Year Survival Among Patients With Ovarian Cancer
|
June 8, 2022
|
PC3I Authors Anna Jo Smith |
Obstetrics and Gynecology
|
|
Real-World Adherence to Patient-Reported Outcome Monitoring as a Cancer Care Quality Metric
|
June 8, 2022
|
PC3I Authors Samuel Takvorian; Peter Gabriel |
JCO Oncology Practice
|
|
Using Informatics to Engage Vulnerable Populations in Research: Lessons Learned from the COVID-19 Pandemic
|
June 8, 2022
|
PC3I Authors George Demiris |
Studies in Health Technology and Informatics
|
|
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice
|
June 7, 2022
|
PC3I Authors Ronac Mamtani; Melina Marmarelis |
Pharmacoepidemiology and Drug Safety
|
|
Guideline discordant care in patients with metastatic germ cell tumors
|
June 6, 2022
|
PC3I Authors |
Urologic Oncology
|
|
Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database
|
June 6, 2022
|
PC3I Authors Emily Ko |
Gynecologic Oncology
|
|
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma
|
June 2, 2022
|
PC3I Authors Ronac Mamtani |
Journal of Cancer Research and Clinical Oncology
|
|
Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis
|
June 2, 2022
|
PC3I Authors Anne Marie McCarthy |
Cancer Medicine
|
|
Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion
|
June 1, 2022
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
